Global Blood Ther (GBT)

We are now approaching the second half of 2019. And it may be time for a little portfolio rebalancing. Biotech stocks often move independently from the market, and these 5 are worth a look.

Oppenheimer’s 7 Top Stock Picks for September

By Harriet Lefton, Writer, TipRanks Aug 28, 2018

Are you looking for a post-summer portfolio boost? Look no further. Oppenheimer bank has just released a bullish report highlighting its Top Stock Picks.

7 Hot Healthcare Stocks Set to Double in 2018

By Harriet Lefton, Writer, TipRanks Dec 26, 2017

These seven healthcare stocks have full marks from the Street. Here's a closer look at what makes these stocks so special.

10 Strong Buy Stocks That Are Better Than Bitcoin

By Harriet Lefton, Writer, TipRanks Dec 14, 2017

If you want to look past the hype of bitcoin and find 10 quality strong buy stocks, then look no further than this list.

3 Soaring Pharmaceutical Stocks That Can Double in a Year

By Harriet Lefton, Writer, TipRanks Sep 1, 2017

These pharmaceutical stocks have two things in common: a 'Strong Buy' analyst consensus rating and upside potential of over 100% from the current share price.

Global Blood Therapeutics Inc (GBT) Stock Soars on Takeover Talk

By Karl Utermohlen, InvestorPlace Writer Mar 8, 2017

Global Blood Therapeutics (GBT) stock is rising as the company is being targeted for a takeover by another pharma corporation. Here's what's happenig

Global Blood Therapeutics (GBT) was downgraded to a Hold Rating at Stifel Nicolaus

From TipRanks Aug 12, 2022

In a report released yesterday, Benjamin Burnett from Stifel Nicolaus downgraded Global Blood Therapeutics (GBT – Research Report) to a Hold, with a price tar...

Global Blood Therapeutics (GBT) was downgraded to a Hold Rating at SVB Securities

From TipRanks Aug 9, 2022

SVB Securities analyst Andrew Berens downgraded Global Blood Therapeutics (GBT – Research Report) to a Hold today and set a price target of $68.50. The compan...

Pfizer Boosts Drug Pipeline with Global Blood Therapeutics Acquisition

From TipRanks Aug 9, 2022

American pharmaceutical giant Pfizer Inc. (NYSE: PFE) is boosting its hematology drug pipeline with the acquisition of Global Blood Therapeutics (NASDAQ: GBT) in a ...

Analysts Are Neutral on Top Healthcare Stocks: Global Blood Therapeutics (GBT), Cerevel Therapeutics Holdings (CERE)

From TipRanks Aug 8, 2022

Analysts fell to the sidelines weighing in on Global Blood Therapeutics (

Pfizer to Buy Global Blood Therapeutics in $5.4 Billion Deal

From Bloomberg Aug 8, 2022

Pfizer Inc. has agreed to buy Global Blood Therapeutics Inc., the maker of a drug for sickle-cell disease, in a deal worth $5.4 billion.

RBC Capital Keeps a Buy Rating on Global Blood Therapeutics (GBT)

From TipRanks Jul 9, 2022

RBC Capital analyst Gregory Renza ...

Global Blood Ther (GBT)

GBT Stock Alert: Pfizer Is Officially Acquiring Global Blood Therapeutics

7 Small-Cap Growth Stocks With 1,000% Upside Potential

7 No-Brainer Biotech Stocks to Add to Your Buy List

HFCAA News: 128 Chinese Stocks the SEC Could Delist

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Global Blood Ther (GBT)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GBT Stock Predictions, Articles, and Global Blood Ther News

Subscriber Sign in